ALIB.HL.INF.TEC.UNSP.ADR Total Liabilities
ALIB.HL.INF.TEC.UNSP.ADR total liabilities. Based on the latest financial reports, ALIB.HL.INF.TEC.UNSP.ADR (TWYA) has total liabilities worth €5.70 Billion EUR (≈ $6.66 Billion USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check TWYA asset liquidity ratio to evaluate the company's liquid asset resilience ratio.
Total Liabilities of ALIB.HL.INF.TEC.UNSP.ADR (2022–2025)
Total liabilities of ALIB.HL.INF.TEC.UNSP.ADR from 2022 to 2025. This chart illustrates how ALIB.HL.INF.TEC.UNSP.ADR's total liabilities have evolved over time, based on quarterly financial data.
ALIB.HL.INF.TEC.UNSP.ADR Competitors by Total Liabilities
The table below lists competitors of ALIB.HL.INF.TEC.UNSP.ADR ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Menora Miv Hld
TA:MMHD
|
Israel | ILA69.86 Billion |
|
NHPC Limited
NSE:NHPC
|
India | Rs645.23 Billion |
|
Columbia Banking System Inc
NASDAQ:COLB
|
USA | $57.83 Billion |
|
10X Genomics Inc
NASDAQ:TXG
|
USA | $204.52 Million |
|
Match Group Inc
NASDAQ:MTCH
|
USA | $4.63 Billion |
|
Shanghai Commercial & Savings Bank Ltd
TW:5876
|
Taiwan | NT$2.23 Trillion |
|
Apogee Therapeutics, Inc. Common Stock
NASDAQ:APGE
|
USA | $141.21 Million |
|
Piraeus Financial Holdings S.A
AT:TPEIR
|
Greece | €72.38 Billion |
Liability Composition Analysis (2022–2025)
This chart breaks down ALIB.HL.INF.TEC.UNSP.ADR's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see ALIB.HL.INF.TEC.UNSP.ADR total assets.
Liquidity & Leverage Metrics
ALIB.HL.INF.TEC.UNSP.ADR Total Liabilities Ratios Explained
ALIB.HL.INF.TEC.UNSP.ADR total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.71 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.32 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.24 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how ALIB.HL.INF.TEC.UNSP.ADR's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for ALIB.HL.INF.TEC.UNSP.ADR (2022–2025)
The table below shows the annual total liabilities of ALIB.HL.INF.TEC.UNSP.ADR from 2022 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-03-31 | €4.87 Billion ≈ $5.69 Billion |
-6.22% |
| 2024-03-31 | €5.19 Billion ≈ $6.07 Billion |
-7.37% |
| 2023-03-31 | €5.60 Billion ≈ $6.55 Billion |
+9.13% |
| 2022-03-31 | €5.13 Billion ≈ $6.00 Billion |
-- |
About ALIB.HL.INF.TEC.UNSP.ADR
Alibaba Health Information Technology Limited, an investment holding company, engages in the pharmaceutical direct sales, pharmaceutical e-commerce platform, and healthcare and digital services businesses in Mainland China and Hong Kong. The company offers a range of prescription and over-the-counter drugs, nutritional supplements, medical devices, contact lenses, healthcare food, adult and famil… Read more